Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.3.14 (
ATP synthase
)
7,042
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Abnormalities of the anterior cingulate cortex have previously been described in schizophrenia,
major depressive disorder
and bipolar disorder. In this study 2-DE was performed followed by mass spectrometric sequencing to identify disease-specific protein changes within the anterior cingulate cortex in these psychiatric disorders. The 2-DE system comprised IPGs 4-7 and 6-9 in the first, IEF dimension and SDS-PAGE in the second dimension. Resultant protein spots were compared between control and disease groups. Statistical analysis indicated that 35 spots were differentially expressed in one or more groups. Proteins comprising 26 of these spots were identified by mass spectroscopy. These represented 19 distinct proteins; aconitate hydratase, malate dehydrogenase, fructose bisphosphate aldolase A,
ATP synthase
, succinyl CoA ketoacid transferase, carbonic anhydrase, alpha- and beta-tubulin, dihydropyrimidinase-related protein-1 and -2, neuronal protein 25, trypsin precursor, glutamate dehydrogenase, glutamine synthetase, sorcin, vacuolar ATPase, creatine kinase, albumin and guanine nucleotide binding protein beta subunit. All but three of these proteins have previously been associated with the major psychiatric disorders. These findings provide support for the view that cytoskeletal and mitochondrial dysfunction are important components of the neuropathology of the major psychiatric disorders.
...
PMID:Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes. 1663 10
Major depressive disorder
(
MDD
) is a leading cause of disability worldwide, although its etiology and mechanism remain unknown. The aim of our study was to identify hub genes associated with
MDD
and to illustrate the underlying mechanisms. A weighted gene co-expression network analysis (WGCNA) was performed to identify significant gene modules and hub genes associated with
MDD
in peripheral blood mononuclear cells (PBMCs) (
n
= 45). In the blue module (
R
2
= 0.95), five common hub genes in both co-expression network and protein-protein interaction (PPI) network were regarded as "real" hub genes. In another independent dataset, GSE52790, four genes were still significantly down-regulated in PBMCs from
MDD
patients compared with the controls. Furthermore, these four genes were validated by quantitative real-time polymerase chain reaction (qRT-PCR) in PBMCs from 33
MDD
patients and 41 healthy controls. The qRT-PCR analysis showed that
ATP synthase
membrane subunit c locus 1 (
ATP5G1
) was significantly down-regulated in samples from
MDD
patients than in control samples (
t
= -2.89,
p
-value = 0.005). Moreover, this gene was significantly differentially expressed between patients and controls in the prefrontal cortex (
z
= -2.83,
p
-value = 0.005). Highly significant differentially methylated positions were identified in the Brodmann area 25 (BA25), with probes in the
ATP5G1
gene being significantly associated with
MDD
: cg25495775 (
t
= 2.82,
p
-value = 0.008), cg25856120 (
t
= -2.23,
p
-value = 0.033), and cg23708347 (
t
= -2.24,
p
-value = 0.032). These findings indicate that the
ATP5G1
gene is associated with the pathogenesis of
MDD
and that it could serve as a peripheral biomarker for
MDD
.
...
PMID:Co-Expression Network Analysis Revealed That the
ATP5G1
Gene Is Associated With Major Depressive Disorder. 3142 35